Search clinical trials for: IDEA-033

Total 1557 results

IDEA AG

Completed

IDEA-033 Open Label Study

Joint Pain | Musculoskeletal Pain | Stiffness | Soft Tissue Inflammation in Designated Target Area(s)

Germany
IDEA AG

Completed

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

Osteoarthritis; Knee
IDEA AG

Completed

An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Nanjing Leads Biolabs Co.,Ltd

Recruiting

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Advanced Malignant Tumors

China
IDEA AG

Completed

Effect of IDEA-070 on Pain and Inflammation Induced by PDT

Actinic Keratosis

Germany
Acceleron Pharma Inc. (a wholly owned subsidiary...

Terminated

Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Canada
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-033 in Patients With Advanced Solid Tumors

Patients With Advanced Solid Tumors

China
Cerecin

Completed

Tricaprilin Phase 2 Pilot Study in Migraine

Migraine

Australia
Liverpool John Moores University
University of Central Lancashire; Queen's University, Belfast; Newcastle University and other collaborators

Completed

Idea Density in Exam Performance (IDEP)

Medical Education | Health Education | Educational Assessment

United Kingdom
Nirsum Labs
National Institute on Drug Abuse (NIDA)

Recruiting

Single Ascending Dose Study of NRS 033 in Healthy Volunteers

Healthy Volunteers

United States
Ohana BioSciences

Unknown

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation (SPRING)

Infertility | Infertility, Male

United States
Alkermes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine

Cocaine Abuse

United States
Major Extremity Trauma Research Consortium
United States Department of Defense

Completed

PRIORITI-MTF Study- Testing Patient Response to the IDEO (PRIORITI-MTF)

Leg Injuries | Trauma

United States
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
Hansa Biopharma AB

Completed

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Kidney Transplant Failure and Rejection

United States, Sweden, France
GE Healthcare

Completed

Evaluation of Orthopedic Knee Measurement Using Lunar iDXA

Hemi Knee Arthroplasty | Patello-femoral Osteoarthritis

New Zealand
Biogen

Terminated

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Colorectal Cancer | Metastases

United States
Merck Sharp & Dohme LLC

Completed

Journey for Control of Diabetes Study (0431-111)

Type 2 Diabetes Mellitus
Hansa Biopharma AB

Active, not recruiting

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Kidney Transplantation in Highly Sensitized Patients

United States
Hansa Biopharma AB

Terminated

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Kidney Transplant Rejection

Germany, France, Austria
Hansa Biopharma AB
Karolinska Institutet; Uppsala University Hospital

Completed

Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation

End Stage Kidney Disease

Sweden
Hansa Biopharma AB

Recruiting

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children (DINKY)

Kidney Transplantation in Highly Sensitized Patients

Spain, Finland, Sweden
Hospital del Mar Research Institute (IMIM)
Parc de Salut Mar; Instituto de Salud Carlos III

Recruiting

Improving Depressive Symptoms Through Personalised Exercise and Activation (IDEA)

Depressive Disorder | Depressive Symptoms

Spain
DoubleGood AB
Lund University; Aventure AB

Completed

Efficacy of Different Doses of Amino Acids in 5AA+CrPic Water on Glucose Homeostasis in a Healthy Population.

Healthy
Children's Hospital Los Angeles

Recruiting

Bright IDEAS for Pediatric Palliative Care: A Problem-Solving Skills Intervention to Empower Parent Resilience

Quality of Life | Psychological Distress

United States
Hansa Biopharma AB
University College London Hospitals

Terminated

IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients

Purpura, Thrombotic Thrombocytopenic

United Kingdom
University of Michigan

Completed

Adapting an Evidence-based Sexual Assault Prevention Intervention for Women Undergraduates for Online Delivery

Sexual Assault

United States
Hansa Biopharma AB

Completed

Safety Study on IdeS in Healthy Volounteers

Healthy

Sweden
Abbott

Completed

Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

HCV Infection

United States
Novo Nordisk A/S

Completed

A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity

Obesity | Overweight

United States
Hansa Biopharma AB

Completed

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Kidney Transplant Rejection

Australia, United States, Germany, France, Austria
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University... and other collaborators

Recruiting

Bright IDEAS - Young Adults Problem-Solving Skills Training

Cancer Patients | Supportive Care | Young Adult

United States
Alkermes, Inc.

Completed

ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence

Alcohol Dependence

United States
Baqiyatallah Medical Sciences University
Tehran University of Medical Sciences; Hamadan University of Medical Science; Tabriz University of Medical Sciences

Not yet recruiting

IDEAL SKIIN CARES Bundle to Prevent Pressure Injury (IdealSkinCares)

Skin Ulcer | Pressure Ulcer | Pressure Injury | Decubitus Ulcer | Pressure Sore | Bed Sore | Decubitus Sore
Longbio Pharma

Active, not recruiting

A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

Chronic Spontaneous Urticaria

China
Utah State University

Completed

Application of Ideal Binary Masking to Disordered Speech

Hearing Loss, Sensorineural | Dysarthria

United States
Huashan Hospital

Enrolling by invitation

A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China

LGMD | LGMDR2 | LGMDR1

China
Novo Nordisk A/S

Completed

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

Obesity | Overweight

United States
Takeda

Completed

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

Schizophrenia

United States
Hansa Biopharma AB

Recruiting

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (PAES)

Kidney Transplantation in Highly Sensitized Patients

Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
Alkermes, Inc.

Completed

ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder

Binge Eating Disorder

United States
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults

Healthy
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness (IDEAL)

Cardiovascular Risk Factors | Serious Mental Illness

United States
Taiho Pharmaceutical Co., Ltd.

Completed

A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects

Healthy Male Subjects

Japan
Hutchison Medipharma Limited
Sun Yat-sen University; Fudan University

Completed

Study of Fruquintinib in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

China
Hutchison Medipharma Limited
Fudan University; Eighty-One Hospital of People's Liberation Army

Completed

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO) (FRESCO)

Colorectal Cancer

China
Hutchison Medipharma Limited
Shanghai Chest Hospital

Completed

A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Ideal Implant Incorporated

Completed

Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants

Breast Implants

United States
Nanjing Leads Biolabs Co.,Ltd

Recruiting

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

China

Search clinical trials for: IDEA-033

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations